SEGLUROMET 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 2.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar control, often alongside diet and exercise. This combination medication targets insulin resistance and glucose absorption, making it a versatile option for diabetes management.

Common effects of Segluromet 2.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users report increased urination or low blood sugar, especially when starting treatment. These effects vary and typically subside as the body adjusts.

Handle Segluromet 2.5 mg/1 with care, especially if you have kidney issues or are prone to dehydration. Regular monitoring of blood sugar levels is advised. Consult a healthcare provider before use if you have existing medical conditions or are taking other medications.

Segluromet 2.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. Alcohol can exacerbate side effects like low blood sugar. Always inform your healthcare provider about all medications you are taking.